DK1083224T3 - Apoptin-associerende protein - Google Patents

Apoptin-associerende protein

Info

Publication number
DK1083224T3
DK1083224T3 DK00203042T DK00203042T DK1083224T3 DK 1083224 T3 DK1083224 T3 DK 1083224T3 DK 00203042 T DK00203042 T DK 00203042T DK 00203042 T DK00203042 T DK 00203042T DK 1083224 T3 DK1083224 T3 DK 1083224T3
Authority
DK
Denmark
Prior art keywords
apoptin
associating protein
novel therapeutic
novel
apoptosis
Prior art date
Application number
DK00203042T
Other languages
English (en)
Inventor
Mathieu Hubertus Mari Noteborn
Oorschot Astrid Adri Danen-Van
Original Assignee
Leadd Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99202858A external-priority patent/EP1081226A1/en
Priority claimed from EP99203465A external-priority patent/EP1108785A1/en
Application filed by Leadd Bv filed Critical Leadd Bv
Application granted granted Critical
Publication of DK1083224T3 publication Critical patent/DK1083224T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK00203042T 1999-09-02 2000-09-01 Apoptin-associerende protein DK1083224T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202858A EP1081226A1 (en) 1999-09-02 1999-09-02 Apoptin-associating protein
EP99203465A EP1108785A1 (en) 1999-10-21 1999-10-21 Apoptin-associating protein

Publications (1)

Publication Number Publication Date
DK1083224T3 true DK1083224T3 (da) 2007-04-10

Family

ID=26153361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00203042T DK1083224T3 (da) 1999-09-02 2000-09-01 Apoptin-associerende protein

Country Status (20)

Country Link
US (2) US7317096B1 (da)
EP (1) EP1083224B1 (da)
JP (1) JP2003510030A (da)
CN (1) CN100513565C (da)
AT (1) ATE347597T1 (da)
AU (1) AU781127B2 (da)
BR (1) BR0013743A (da)
CA (1) CA2383784A1 (da)
CY (1) CY1106355T1 (da)
DE (1) DE60032201T2 (da)
DK (1) DK1083224T3 (da)
EA (1) EA005933B1 (da)
ES (1) ES2277815T3 (da)
HU (1) HUP0202688A2 (da)
IL (2) IL148469A0 (da)
NO (1) NO20021067L (da)
NZ (1) NZ517740A (da)
PL (1) PL204275B1 (da)
PT (1) PT1083224E (da)
WO (1) WO2001016165A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784723B2 (en) * 1999-12-10 2006-06-01 Leadd B.V. Apoptin-associating protein
ES2525065T3 (es) 2008-04-11 2014-12-17 Merrimack Pharmaceuticals, Inc. Ligadores de seroalbúmina humana y sus conjugados
WO2011100428A2 (en) * 2010-02-10 2011-08-18 The Uab Research Foundation Compositions for improving bone mass

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
EP0878546A1 (en) * 1997-04-15 1998-11-18 Leadd B.V. A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
ES2249774T3 (es) 1994-12-22 2006-04-01 Novartis Ag Proteinas serina/tronina quinasas nucleares.
JPH11506340A (ja) * 1995-06-07 1999-06-08 アエスキュラープ ビー．ヴィ． アポプチンの利用と方法
CA2283299A1 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
KR20010022812A (ko) * 1997-08-12 2001-03-26 리드 비.브이. 인자의 변형능력을 측정하는 방법
EP0924296A3 (en) * 1997-12-03 2001-08-01 Leadd B.V. Methods and means for inducing apoptosis by interference in RNA processing
EP0921192A1 (en) * 1997-12-03 1999-06-09 Leadd B.V. Molecules interacting with apoptin
EP0927757A1 (en) * 1997-12-03 1999-07-07 Leadd B.V. Methods and means for inducing apoptosis by interfering with Bip-like proteins
US20030105315A1 (en) 1998-04-09 2003-06-05 Metagen Pharmaceuticals Gmbh Human nucleic acid sequences from ovarian tumor tissue
AU3885999A (en) * 1998-05-05 1999-11-23 Incyte Pharmaceuticals, Inc. Human transcriptional regulator molecules
AU784723B2 (en) 1999-12-10 2006-06-01 Leadd B.V. Apoptin-associating protein
EP1106691A1 (en) 1999-12-10 2001-06-13 Leadd B.V. Apoptin-associating protein
EP1111045A3 (en) 1999-12-10 2001-09-19 Leadd B.V. Apoptin-associating protein
WO2001053351A2 (en) 2000-01-17 2001-07-26 Leadd B.V. Apoptin bindendes protein
EP1138765A1 (en) 2000-03-27 2001-10-04 Leadd B.V. Apoptin-associating proteins AAP-5 and AAP-6

Also Published As

Publication number Publication date
PL354285A1 (en) 2003-12-29
IL148469A0 (en) 2002-09-12
CN1387569A (zh) 2002-12-25
AU7324200A (en) 2001-03-26
NZ517740A (en) 2003-09-26
JP2003510030A (ja) 2003-03-18
EP1083224A2 (en) 2001-03-14
DE60032201T2 (de) 2007-09-20
EP1083224A3 (en) 2001-04-25
PL204275B1 (pl) 2009-12-31
US7767790B2 (en) 2010-08-03
EA005933B1 (ru) 2005-08-25
NO20021067D0 (no) 2002-03-04
CA2383784A1 (en) 2001-03-08
BR0013743A (pt) 2005-01-11
ATE347597T1 (de) 2006-12-15
CY1106355T1 (el) 2011-10-12
PT1083224E (pt) 2007-03-30
ES2277815T3 (es) 2007-08-01
HUP0202688A2 (en) 2002-12-28
EA200200321A1 (ru) 2002-08-29
AU781127B2 (en) 2005-05-05
US7317096B1 (en) 2008-01-08
US20080176231A1 (en) 2008-07-24
DE60032201D1 (de) 2007-01-18
WO2001016165A2 (en) 2001-03-08
CN100513565C (zh) 2009-07-15
EP1083224B1 (en) 2006-12-06
WO2001016165A3 (en) 2001-09-20
NO20021067L (no) 2002-05-02
IL148469A (en) 2009-02-11

Similar Documents

Publication Publication Date Title
DE60215848D1 (de) 1,2,4-thiadiazolverbindungen als melanocortinrezeptor-modulatoren
SV2003001144A (es) FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
EA200400241A1 (ru) Направленные к мишени мультимерные контрастные вещества, основанные на пептидах
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
DK0713529T3 (da) Vækst-/differentieringsfaktor af TGF-beta-familien
EA200200105A1 (ru) СОЕДИНЕНИЯ, МОДУЛИРУЮЩИЕ АКТИВНОСТЬ PPARγ;
DK1187632T3 (da) Behandling med anti-ErbB2-antistoffer
PL339860A1 (en) Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline
DE60206574D1 (de) Entnahmegefässanordnung
DE69722734D1 (de) Sterile Phiolenverbindung zur Übertragung von Flüssigkeit
NO20055010D0 (no) Preparater inneholdende laktulose for behandling av potavirusinfeksjoner
EA200000519A1 (ru) 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
ATE299183T1 (de) Apoptose induzierende proteinesubstanz
DK1083224T3 (da) Apoptin-associerende protein
DE60332579D1 (de) Prozess zur Immobilisierung von Polypeptiden über die Carboxylgruppe des C-terminus
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
WO2001072825A3 (en) Apoptin-associating protein
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DE60038955D1 (de) AN DER OBERFLÄCHE VON KARZINOMZELLEN LOKALISIERTES COLLIGIN/HsP47
WO2001042461A3 (en) Apoptin-associating protein
EP1111045A3 (en) Apoptin-associating protein
WO2001053351A3 (en) Apoptin bindendes protein